Skip to main content
. 2021 Apr 7;21:165. doi: 10.1186/s12872-021-01970-2

Table 1.

Inclusion and exclusion criteria

Inclusion criteria Exclusion criteria
Woman aged > 18 years and < 70 years Patients with previous history of heart disease or heart failure
First diagnosis of breast cancer at early stages (I, II, III) Left ventricular dysfunction (left ventricular ejection fraction < 53%) at baseline
Patients who will receive adjuvant or neoadjuvant treatment with curative intention Metastatic disease
Treatment with anthracyclines and/or anti-HER-2 antibodies (trastuzumab and pertuzumab) Patients carrying an implantable cardioverter defibrillator
Possibility of completing a cardiac rehabilitation program and programmed visits Patients with physical or mental limitation to carry out an exercise program
Providing written informed consent Refuse to participate
Overcome 20% of cardiotoxic treatment